Alpha Profiles · Company Profile

Aptevo Therapeutics Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/aptevo-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: APVO
Verification: Partially verified
Last reviewed: 2026-09-17T04:47:17.740447+00:00

Overview

Alpha's canonical identity and public leadership record for Aptevo Therapeutics Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

4 public records

Daphne Taylor

Senior Vice President, Chief Financial Officer

State: confirmed
Effective: From Mar 26, 2026
Confidence: 94%
Evidence: APVO 10-K executive officersMar 26, 2026

Jeffrey G. Lamothe

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-376763Aug 31, 2026

Marvin L. White

President and Chief Executive Officer

State: confirmed
Effective: From Mar 26, 2026
Confidence: 94%
Evidence: APVO 10-K executive officersMar 26, 2026

SoYoung Kwon

SVP, General Counsel, Business Development and Corporate Affairs

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-376763Aug 31, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 17, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.